For disease-free survival patients with high FEZF1-AS1 expression had a significantly poorer prognosis than those with low FEZF1-AS1 expression in gastric cancer patients (P <0.05, log-rank test; Fig. 2d). The gene discussed is FEZF1; the disease is gastric cancer.